NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Overview Fund Activity
Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

27 hedge funds and large institutions have $4.43M invested in NKGen Biotech, Inc. Warrants in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
1
Closed
3
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
+$34K

Top Buyers

1
PC
1
Periscope Capital
Ontario, Canada
$137K
2
DCM
2
Difesa Capital Management
New York
$126K
3
KC
3
Kepos Capital
New York
$121K
4
VCIM
4
Velan Capital Investment Management
Georgia
$23K
5
Bank of America
5
Bank of America
North Carolina
$23K

Top Sellers

1
AIMCA
1
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$0
2
EAM
2
Exos Asset Management
New York
$0
3
EIP
3
Easterly Investment Partners
Massachusetts
$0
4
Walleye Capital
4
Walleye Capital
New York
$12K
Name Market Value Shares Shares
Change 		Shares
Change %
Walleye Capital
26
Walleye Capital
New York
$12K 10,192 -288 -3%
CCM
27
CAAS Capital Management
New York
$12K 10,000 +10,000 New
FLC
28
Fifth Lane Capital
Texas
$12K 10,220 +10,220 New
AIMCA
29
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– – -40,000 Closed
EAM
30
Exos Asset Management
New York
– – -14,000 Closed
EIP
31
Easterly Investment Partners
Massachusetts
– – -10,000 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
Millennium Management
33
Millennium Management
New York
– – – –
1
2